Cryo Cell International CCEL
NYSE CCEL
$4.20 +0.15 (+3.70%)
At close: Sep 30, 2026 · 4:00 PM EDT

Cryo Cell International (CCEL) Return on Equity [ROE] (2021 - 2022)

Updated

Cryo Cell International (CCEL) recorded Return on Equity [ROE] of 208.38% in FY2022 (year ended Nov 30, 2022), down 65.92 percentage points from 274.30% in FY2021.

Analysis

Cryo Cell International (CCEL) Return on Equity [ROE] (2021 - 2022) Analysis & Trends

  • Per Business Quant data, CCEL's Return on Equity [ROE] was 274.30% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 HCA Healthcare 93.06 Bn 92.50 Bn - -
2 Natera 59.36 Bn 55.04 Bn 485.19 Mn -10.70%
3 Quest Diagnostics 25.72 Bn 24.15 Bn 1.03 Bn 14.38%
4 Labcorp Holdings 24.93 Bn 22.69 Bn 1.11 Bn 11.58%
5 Guardant Health 23.83 Bn 19.89 Bn 219.03 Mn -
6 Tenet Healthcare 20.58 Bn 11.72 Bn - 47.84%
7 Tempus AI 14.35 Bn 11.38 Bn 246.50 Mn -57.32%
8 Encompass Health 11.99 Bn 12.46 Bn - 24.83%
9 BrightSpring Health Services 11.21 Bn 9.55 Bn 492.75 Mn 18.16%
10 Cryo Cell International 33.86 Mn 21.28 Mn 6.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2022 128.26%
May 31, 2022 38.95%
Feb 28, 2022 52.68%
Nov 30, 2021 46.39%
Aug 31, 2021 89.08%
May 31, 2021 333.49%
API Access

Cryo Cell International Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CCEL&period=max&api_key=YOUR_API_KEY